Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial - Hoeper, M M; Al-Hiti, H; Benza, R L; REPLACE investigators (Lancet Respir Med, 2021)